NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

I find it very curious that last year’s run up to ASCO shot the share price up to $2.15, but this year, after all the positive manufacturing developments, FDA publication on ECAs, new patents, new studies, more combo data, etc., the stock can’t even break $1. Just 300 shares brings it down yet again.

It is as if someone is trying really hard to contain SP. They are in a ‘quiet’ period, and yet they bought a promotional Product Theater with plans to present something by Marnix Bosch, a scientific officer of the company. That doesn’t look very quiet to me.

$0.92 are you kidding me?